Navigation Links
OrbusNeich's Genous™ Stent Shows Favorable Outcomes for Treatment of Coronary Artery Bifurcation Lesions Compared to Bare Metal Stents
Date:12/2/2010

HONG KONG, Dec. 2, 2010 /PRNewswire/ -- OrbusNeich's Genous Stent shows favorable outcomes compared to bare metal stents (BMS) for the treatment of coronary artery bifurcation lesions, according to data published online in the journal Atherosclerosis.

The cumulative rate of the study's primary endpoint, the composite of cardiac death, myocardial infarction (MI) or target lesion revascularization (TLR) at one year follow-up, was 12.4% in patients treated with a Genous Stent, a 30% reduction compared to 17.2% for the control group treated with BMS.  The definite or probable stent thrombosis (ST) rate was 1.7% for the Genous Stent patient group, compared to 3.4% for the BMS treated patient group.

"Interventional cardiologists continue to be challenged by the 15 to 20% of all percutaneous coronary interventions that involve coronary artery bifurcation lesions," said Marcel Beijk, M.D., of the Academic Medical Center in Amsterdam, the lead author of the paper. "The results of this large study of provisional T-stenting using the Genous Stent are extremely encouraging. The endothelial progenitor cell capture stent provides an excellent alternative to bare metal stents for the treatment of these challenging lesions."

The paper, titled "One-year clinical outcome after provisional T-stenting for bifurcation lesions with the endothelial progenitor cell capturing stent compared with the bare-metal stent," is based on a single-center, non-randomized study. The study involved 178 consecutive patients who underwent percutaneous coronary intervention for a de novo bifurcation lesion treated with a Genous Stent and 465 consecutive patients treated with BMS.

About Genous

Genous is OrbusNeich's patented endothelial progenitor cell (EPC) capture technology that promotes the accelerated natural healing of the vessel wall after
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Randomized Clinical Trial of OrbusNeichs Genous™ Bio-engineered R stent™ in China Completes Patient Enrollment
2. Data from Multiple Clinical Trials of OrbusNeichs Genous™ Bio-engineered R Stent™ Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT 2010
3. OrbusNeichs Genous™ Bio-engineered R stent™ Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease
4. 100 Percent Coverage of Struts and Complete Neointimal Coverage of OrbusNeichs Genous™ Bio-engineered R stent™ Demonstrated 26 Days Post-Implantation in STEMI Patient
5. Data Show OrbusNeichs Genous™ Bio-engineered R stent™ is Safe and Effective in Combination with Drug-Eluting Balloon
6. Blue Medical Receives European CE Mark Approvals for Drug Eluting Balloon and Stent on Drug Eluting Balloon Combination Device
7. Endologix Announces First Clinical Implant of Ventana™ Stent Graft
8. Boston Scientific Announces CE Mark Approval for Expanded Indication of WallFlex® Biliary RX Stent
9. Boston Scientific Announces FDA Clearance and CE Mark Approval for Advanix™ Biliary Stents
10. MultiCells Majority Owned Subsidiary Acquires Bioabsorbable Interventional Cardiology Stent Assets
11. Canadian Health Care System Pressuring Manufacturers to Lower Drug-Eluting Stent Prices in US$55 Million Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 2015 Agena Bioscience TM today announced the ... a commercial and financial hub from which many biotech and ... laboratories in mainland China . ... global sales with almost sixty MassARRAY ® Systems installed ... will allow us to expand our reach and foster a ...
(Date:9/1/2015)... In nur zwei Jahren nach dem ... SHL Group schnell weltweit 3.000 Mitarbeiter erreicht. Diese ... dem Markt der injizierbaren Medikamente und ... von SHL wieder. Foto - ... in Design und Herstellung automatischer Injektoren und Pen-Injektoren ...
(Date:9/1/2015)... WAYNE, Pa. , Sept. 1, 2015 /PRNewswire/ ... a fully integrated specialty pharmaceutical company focused on ... announced that researchers will be  presenting scientific data ... Egalet-001, an abuse-deterrent, extended-release, oral morphine product candidate, ... in development, at PainWeek 2015 to ...
Breaking Medicine Technology:Agena Bioscience Opens Office in Shanghai, China 2SHL Group erreicht wichtigen Markstein von 3.000 Mitarbeitern 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 3Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 4Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 5Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 6
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... is proud to announce its new fall collection. Every customer who buys an ... part of the company’s environmental partnership with Trees for the Future, a nonprofit ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... company, is pleased to announce their partnership with Apex Physical Therapy ... groups to continue to provide kind, compassionate, and empathetic care to local residents ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... not managed, stress created from everyday life changes can lead to very serious, ... provide support for coping with stress. Herbal supplement manufacturer MediHerb has ...
(Date:9/1/2015)... ... September 01, 2015 , ... From Aug. 17-21, Calvary Hospital hosted the ... 6-18. Calvary’s Camp Compass® has taken place at Kingsborough Community College in Brooklyn in ... of whom work for Calvary, and two junior counselors who were campers themselves just ...
(Date:9/1/2015)... New Jersey (PRWEB) , ... September 01, 2015 , ... ... one of the 50 Best Companies for Latinas in the LATINA Style 50 Report ... United States. , For 2015, Horizon BCBSNJ climbs from number 24 ...
Breaking Medicine News(10 mins):Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 2Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 3
... evaluation have incidental findings, according to a study performed ... Columbus, OH. , Incidental findings during trauma evaluation ... the diagnosis and management of those findings. The study ... underwent CT of the cervical spine during an initial ...
... 3 They,re one of the ... overuse of antibiotics can have great ... report from Ortho-McNeil-Janssen Pharmaceuticals at: , ... video, audio, text, graphics and photos ...
... IntelliSoft Group is a leading provider of medical credentialing software. ... professionals to be more efficient in their credentialing tasks. , ... ... as IntelliSoft Group, has announced the release of version 9.0 of ...
... Threats Require Healthcare Sustainability for America,s Hospitals ... The Healthcare Waste and Emergency Preparedness ... awareness and provide education about two major ... healthcare facility operational sustainability during a crisis ...
... On the eve of President Obama,s healthcare summit ... said today that expanding and updating Medicare to ... approach to achieving the goals and principles outlined ... Congress and budget proposal.While welcoming President Obama,s call ...
... and ousted officers of UHW engaged in pattern to ... as officers and employees, despite fiduciary duties OAKLAND, Calif., ... West (UHW) today filed suit in US District Court ... and other disgraced former officers of the local union ...
Cached Medicine News:Health News:IntelliSoft Group Announces Version 9.0 ,Enhancing and Improving IntelliCred Software 2Health News:The Healthcare Waste and Emergency Preparedness Coalition Announces Its Official Formation 2Health News:Nation's RNs on the Healthcare Summit: Insurance-Based Reform Will Fail, and Undermine Public Trust, Only Medicare for All Can Achieve Administration's Goals 2Health News:Nation's RNs on the Healthcare Summit: Insurance-Based Reform Will Fail, and Undermine Public Trust, Only Medicare for All Can Achieve Administration's Goals 3Health News:UHW Trustees File Federal Suit Against Former Officers for Undermining Members 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: